Enzymatic Vesication In Vivo I. Effects of Papain in Human Skin**From the Department of Dermatology, (Dr. Rolf F. Miller, Clinical Instructor of Dermatology, and Dr. Richard B. Stoughton, Director of Dermatology), Western Reserve University Medical School, Cleveland, Ohio.Supported by U.S. Dept. Public Health and Welfare Grant No. A2196 by Miller, Rolf F. & Stoughton, Richard B.
ENZYMATIC VESICATION IN VIVO
I. EFFECTS OF PAPAIN IN HUMAN SKIN*
ROLF F. MILLER, M.D. AND RICHARD B. STOUGHTON, M.D.
Recent work has indicated that acantholysis
can be induced by enzymatic factors present in
human skin (1, 2, 3). Mild thermal injury and
cantharidin application to human skin in vitro
will induce an enzymatic breakdown of epidermal
cells as well as dermal-epiderinal separation.
Fairly recent reviews cover current knowledge
of blister formation and cutaneous proteolytic
enzymes (4, 5, 6, 7), so the subject will not be re-
viewed in detail here.
It has recently been shown that acantholysis
can be induced in vitro in human skin by crystal-
line papain and elastase (1) whereas trypsin, ly-
sozyme, and a large group of other crystalline
enzymes did not induce acantholysis in vitro
Because of the in vitro effects of papain (1) it was
decided to observe skin of human volunteers in-
jected with crystalline papain.
This report concerns the fact that one can in-
duce in vivo the following changes by intradermal
injection of the single crystalline enzyme, papain:
a) spongiosis and spongiotic vesication, b) acan-
tholysis and c) dermal-epidermal separation.
msTonv
Papain can be obtained as a crystalline prepa-
ration derived from papaya latex. It has been
known for a long time that partially purified as
well as crystalline derivatives of papaya latex
will hydrolyze many types of synthetic peptide
substrates (8). Crystalline derivatives of papaya
latex also behave as powerful esterases and there-
by resemble the animal proteinases trypsin and
chymotrypsin, but differ in their requirement of
sulfhydryl groups for activity and in their high
resistance to inactivation by di-isopropyl-
fluorophosphate (9).
Detailed biochemical studies of crystalline
papain including methods for preparation, activa-
tion and inactivation, synthetic substrates, arid
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composition have been recently published (10).
A large number of synthetic substrates for crystal-
line papain have been reported. These include
a) carbobenzoxyl-L-glutamyl-L-tyrosine, b) car-
bobenzoxyglycyl-L-tryptophan, c) benzylarginine
amide, d) acetyl-L-tyrosinamide, and e) L-leu-
cinamide. The first four of the above are specific
substrates for papain, carboxypeptidase, trypsin,
and chymotrypsin, respectively. Papain will also
hydrolyze other synthetic substrates and
obviously has a wide range of peptidase activity
as well as esterase activity.
A most interesting biologic effect of papain was
recorded by Thomas after he observed the collapse
of rabbit ears after intravenous injection of
papain (11). Further experiments (12) revealed
that papain is deposited in the rabbit ear and
apparently hydrolyzes the matrix of cartilage and
releases chrondroitin sulfate (13).
This activity of papain is dependent upon free
sulfhydryl groups, although crystalline papain
containing free sulfhydryl groups is inactive when
given intravenously. Presumably the sulfhydryl
papain is bound before it can be deposited in the
rabbit ear. Papain can be inactivated in situ by
adding sulfhydryl binding agents and it can then
be reactivated by adding cysteine to the in-
activated preparation (12).
Fm. 1. Dermal-epidermal separation one hour
following intracutaneous injection of a 1:10 papain
solution. Mild dermal, chiefly perivascular in-
filtrate. Hematoxylin and Eosin. X 86.
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FIG. 2. Subepidermal vesicle two hours after intracutaneous injection of a 1:10papain solution. H.
and E. X 150.
FIG. 3 Subepidermal vesicle four hours after intracutaneous injection of a 1:10 papain solution H.
and E. X 100.
Other than the recent report of acantholysis
induced in human skin in vitro (1) by papain we
know of no reports concerning its direct action
on human skin.
METHODS
The experiments were performed on two male
individuals 37 and 68 years of age with healthy,
morphologieally normal appearing skin. Crystal-
line papain with 0.03% cysteine in saline solution
was used. f The enzyme was diluted 1: 10 and 1:3
in trihydroxymethylaminomethane buffer, pH
7.4. One-tenth (0.1) ml. of the solution was in-
jected intradermally with a 26-gauge needle as
superficially as possible into the skin of the back.
For controls papain solution of similar concen-
trations were used, but were previously heated to
1000 C. for 10 minutes.
t Supplied by Worthington Biochemical Labo-
ratories, New Jersey
r
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Papain in 1:10 dilution was injected at four
different sites on the back of one of the two indi-
viduals. For histopathologic examination a punch
biopsy under local procaine anesthesia was done
on each site, one lesion being removed each hour
commencing one hour after the injection. Care
was exercised to remove the central portion of
the lesion with the vesicle intact. Similarly at
four different sites on the back the control solu-
tion was injected. Punch biopsy specimens were
also takeii from the central portions of these de-
veloping lesions, at one hour intervals.
The back of the other individual was injected
with the 1:3 papain solution at three different
sites, and a punch biopsy of one of these three
areas was performed every hour, starting one hour
after injection. The heated papain 1:3 control
solution was injected at three different sites, and
FIG. 4. Beginning spongiosis throughout the epidermis two hours after intracutaneous injection of a
1:10 papain solution. II. and E. X 275.
Fin. 5. Beginning spongiosis within the epidermis, two hours after injection H. and E. X 1100.
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FIG. 6. Marked spongiosis with intraepidermal vesicle formation four hoors followiog intracutaneous
injection of a 1:10 papain solution. H. and E. X 200.
FIG. 7. Three hours following injection of a 1:10 papain solution intracutaneously changes resembling
liquefaction degeneration of the basal cell layer can be seen. H. and E. X 275.
FIG. 8. Beginning subepidermal vesiculation is demonstrated in this section, removed four hours
following injection of a 1:10 papain solution. H. and E. >< 180.
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these were subsequently biopsied at one hour in-
tervals. All specimens from the control and ex-
perimental sites were sectioned after 10% forma-
lin fixation, dehydration, and paraffin imhcddiog.
The sections were stained with hematoxylin and
eosin.
RESULTS
A. Papain 1:10 Dilution
All injections produced wheals of approxi-
mately 5 mm. in diameter at which site the skin
was blanched. One hour after injection an erythem-
atous, slightly elevated wheal of 1j. cm. in
diameter had developed surrounding the site at
which the needle had been inserted. Two hours
later a small vesicle measuring 2 mm. was visible
in the central portion of the wheals. It was noted
that during the observed period of time (up to
seven hours) both wheals and vesieles were per-
sistent and showed no tendency to fade.
Injections with the heated 1:10 papain solution
were followed by the appearance of erythematous
wheals, which were smaller than those produced
by the unheated active enzyme solution and aver-
aged em. in diameter. In no instance was a
vesiele observed. Some of these wheals had al-
most completely faded four hours following in-
jection.
Although macroseopically a vesicular lesion
was not recognizable on the specimen removed
one hour following injection, under the micro-
scope a small area of dermal-epidermal separa-
tion was visible (Fig. 1). The specimens removed
Fia. 10. Suhepidermal blister, containing fluid and numerous erythroeytes, two hours following in-
traeutaneous injection of a 1:3 papain solution. H. and E. x80.
FIG. 9. Wheal on left upper hack with centrally
located hemorrhagic vesiele 4 mm in diameter.
Photograph was taken one hour following in-
traeutancous injection of a 1:3 papain solution.
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FIG. 11. Adjacent area to blister shown in fig. 10 with intraepidermal disruption of collagen fibers, H.
and E. x 80.
Fjo. 12. Large aeantholytie vesiele four hours following injection (papain 1:3). Epidermis in dissolu-
tion. H. and E. X 80.
FIG. 13. Subepidermal separation and beginning acantholysis of epidermis adjacent to vesiele shown
in Fig. 12. In addition spongiosis can be seen on the right. H. and E. X 80.
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2, 3, and 4 hours following injection morpholog-
ically presented a vesiele. Again, under the micro-
scope the vesiele was seen to he at the dermal-
epidernial junction (Figs. 2 and 3). The maximum
degree of dermal—epidermal separation apieare I
over the site of injection. Various degrees of spon-
giosis can be seen witlnn the epidermis adaeent
to the area of dermal-epidermal separation (Figs.
4, 5, and 6). Spongiosis is most marked iii the
fonr-hour specimen. In addition very early
changes involving the basal cell layer of the epi-
dermis can he seen, resembling liquefaction de-
generation (Figs. 7 and 8). Dermal changes are
characterized by slight disruption of collagen
fibers and by the presence of a moderate degree of
cellular infiltration consisting mainly of poly-
morphonuclear cells, round cells, and many eo-
sinophils. In part the infiltrate is perivasenlar in
FIG. 14. Acantholytic epidermal and peculiar vacuolated cells, probably representing sebaceous cells
within acantholytie blister. H. and E. X 440.
FIG. 15. Acantholytic prickle cells freely floating in blister fluid. H. and E. X 882.
arrangement and this is most marked in an area
below the epidermal changes. The later the speci-
men was removed, the denser the cellular accu-
mulation within the dermis. Only minimal de-
grees of acantholysis of epidermal cells were seen.
Histologically, the control areas did not show
epidermal changes. There was a mild dermal in-
filtrate, chiefly perivascular, consisting of round
cells, polymorphonuclcar cells, histiocytes, and a
very occasional cosinophil.
B. Papain 1:3 Dilution
One hour following injection of the active en-
zyme solution crythematous and markedly ele-
vated wheals measuring 2j cm. in diameter had
developed and vcsicles were already visible in
the central portions of the lesions at that time.
These vcsicles were larger than those produced
by the 1:10 papain solution, measuring between
3 and 4 mm. in diameter. The lesions were some-
what reddish in color and the vesicular fluid
seemed to contain fresh blood (Fig. 9).
On histologic examination the macroscopically
visible vesiclc is seen to be subcpidermal in na-
ture (Fig. 10). Dermal-epidermal separation ap-
pears to occur cspecial]y at the site of injection.
The dermis is the site of mild infiltration with
some perivascular arrangement, composed chiefly
of polymorphonuclear cells and round cells. The
vcsicle fluid contains numerous erythrocytes.
Spoagiosis within the epidermis is seen in areas
adjacent to the vesicle (Fig. 11). The specimen
removed four hours following injection shows
histologically clear-cut acantholysis (Fig. 12). In
this section the epidermis is partially dissolved in
its structure and acantholytic cpidermal cells arc
freely floating in the vesicle, the roof of which is
formed by the preserved stratum corneum. Both
sub-epidermal separation and severe spongiosis
are seen in epidermal regions adjacent to the
acantholytic area (Fig. 13). Peculiarly shaped
large vacuolatcd cells with a small nucleus are
seen floating free in the blister fluid together with
cpidermal cells (Figs. 14 and 15). It is believed
that these cells represent either degenerated
cpidcrmal cells or sebaceous cells. The latter
interpretation is more probable since the process
of enzymatic cellular disruption is seen extending
into the hair follicles and adncxal structures. In
areas, chiefly above the injection site, the first
stages of acantholysis can be observed, showing
cpidcrinal cells in their normal situation, clearly
separated from each other by cleft-like spaces
devoid of intercellular bridges (Fig. 16).
The heated control papain solution, 1:3 dilu-
tion, also produced a wheal at the site of injec-
tion. These wheals were equal in size to the ones
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Fin. 16. Acantholytic prickle cells in situ, separated from each other by cleft-like spaces. H. and E.
X 840.
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which developed following injection of the 1:10
papain solution, and no vesicles were observed.
The microscopic picture of the specimens from
the control areas correspond with those observed
following injection of the heated 1:10 papain
solution. No epidermal changes were seen.
The only subjective symptom following these
injections was pruritus. In neither instance was
necrotic tissue breakdown at the sites of the
injections observed. Without the biopsy the
healing process was uneventful and required two
to three days.
DISCUssION
The most interesting observation is that a
single crystalline enzyme is capable of inducing
in vivo in perfectly normal skin not only all the
morphological changes of the eczematous reac-
tion, but dermal-epidermal separation, and, with
higher concentrations, definite acantholysis as
well.
It seems that the lower the concentration of
crystalline papain in a given area the more likely
is there to be spongiosis rather than dermal-
epidermal separation or ncantholysis.
Naturally one must speculate as to the exist-
ence of such an enzymatic mechanism in human
skin which might be a responsible agent in the
pathogenesis of cczematous responses, dermal-
epidermal separation, and ncantholysis. This
can be compatible with the obviously different
etiologic agents, as such an enzyme would be a
mediator of the pathologic response rather than
an inducing agent. Again, previous work has
shown that acantholysis dependent upon enzy-
matic factors within human skin can be induced
by mild thermal injury, and cantharidin (1, 2).
Evidence seems to be accumulating to support
the theory of enzymatic mediators responsible
for vesicant diseases.
Potassium chloride extracts of skin have been
shown to contain many protenses, but injection
of these extracts into human skin does not induce
spongiosis, acantholysis, or dermal-epidennal
separation (14).
It is most probable that spontaneous formation
of blisters in disease is not as simple as one might
be tempted to conclude from our experiments.
Whether one single enzyme or several enzymes or
inactivators of physiologic inhibitors (5) are re-
sponsible for blister formation in disease remains
to be shown.
SUMMARY
1) There is evidence that one or several
enzymatic factors are related to the patho-physio-
logic mechanism of blister formation in the hu-
man epidermis.
2) Crystalline papnin was employed in vivo to
elicit vesiculation of the human epidermis.
Spongiosis, dermal-epidermal separation, and
ncantholysis of epidermal cells are demonstrated
in the histopathological picture.
3) The higher the concentration of pnpain the
more likely will ncautholysis develop, while areas
of less concentrated papain are more likely to
show spongiosis and/or dermal-epidermal separa-
tion. The most fascinating observation is that a
single enzyme preparation will induce in vivo all
three of these morphologic changes.
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